239 results
Page 3 of 12
8-K
8gp4t02h 3w1
27 Oct 22
Kineta to Present Pre-clinical Data on VISTA and CD27 Programs at SITC 2022 Annual Meeting
7:13am
425
yv6uyhsi gzqoi
26 Oct 22
Business combination disclosure
5:17pm
8-K
6cw jvfswv6
26 Oct 22
Regulation FD Disclosure
5:14pm
425
4wkyi4aqaj957
26 Oct 22
Business combination disclosure
5:10pm
8-K
au73iamgg1 v5h
26 Oct 22
Regulation FD Disclosure
5:08pm
425
pnne4dyk147089
24 Oct 22
Business combination disclosure
8:00am
8-K
EX-10.2
i4dn g6a9dlww7
24 Oct 22
Entry into a Material Definitive Agreement
7:59am
425
cs9ykxj4j0s
17 Oct 22
Business combination disclosure
4:03pm
8-K
v7jk0ul vy11po4
17 Oct 22
Clinical trial anticipated to begin in late 2022
4:02pm
425
ug890tfl38zu50
13 Oct 22
Business combination disclosure
4:03pm
8-K
63x1rtlfi92h3fp
13 Oct 22
Kineta to Present Anti-CD27 Agonist Preclinical Program at AACR Conference on Tumor Immunology and Immunotherapy
4:01pm
425
2f8vs4amzr
11 Oct 22
Business combination disclosure
8:02am
8-K
p9hwprhh
11 Oct 22
Kineta Announces Participation in Upcoming October 2022 Investor Conferences
8:00am
425
hlzkui
4 Oct 22
Business combination disclosure
4:04pm
8-K
3mmdc5rhhb8h
4 Oct 22
Kineta Appoints Keith Baker as Chief Financial Officer
4:01pm